RISK FACTORS AND A THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISORDERS
    2.
    发明申请
    RISK FACTORS AND A THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISORDERS 审中-公开
    风险因素和治疗神经病变的治疗目标

    公开(公告)号:US20110177509A1

    公开(公告)日:2011-07-21

    申请号:US13055569

    申请日:2009-07-10

    IPC分类号: C12Q1/68 C07H21/00 C40B40/06

    摘要: Compositions and methods for detecting a neurodegenerative disorder, and methods of treating a neurogenerative disorder are disclosed. Biomarkers for a neurodegenerative disorder containing a polymorphism in the nucleotide sequence of PP3R1, GSK3beta, PPP3CA, FYN, WISP1, MGEA5, CTSD, F2, MAPT, OGT or PRKCA are also disclosed. A method for detecting a neurodegenerative disorder by detecting polymorphisms in the above genes is further disclosed.

    摘要翻译: 公开了用于检测神经变性疾病的组合物和方法,以及治疗神经发生障碍的方法。 还公开了含有PP3R1,GSK3beta,PPP3CA,FYN,WISP1,MGEA5,CTSD,F2,MAPT,OGT或PRKCA的核苷酸序列中的多态性的神经退行性病症的生物标志物。 进一步公开了通过检测上述基因中的多态性来检测神经变性疾病的方法。